Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir

NCT05624840 · clinicaltrials.gov ↗

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Chronic Kidney Disease stage4
Chronc Kidney Disease Stage 5

Interventions

DRUG: Nirmatrelvir/ritonavir

Sponsor

Chinese University of Hong Kong